Topic List : Immunology
Finding the immune clock of pregnancy
A woman’s immune system changes throughout a normal pregnancy in a highly orchestrated manner, Stanford researchers have found. The findings lay the groundwork for tests to predict preterm birth.
Seasonal gut-microbe fluctuation
Scientists from Stanford and their collaborators have linked a traditional population’s seasonally varying diet to cyclical changes in the number of gut-residing microbial species.
Falkow’s legacy of mentorship
The legendary microbe hunter has helped launch the careers of more than 100 scientists, including those of several Stanford faculty members.
Animals don’t fully mimic human immune response
“Humanized” mice are used to study human immune responses, but they are inadequate for stem cell studies, say Stanford researchers. Optimized models are needed for clinical decision-making.
Chronic fatigue syndrome biomarkers found
Stanford investigators used high-throughput analysis to link inflammation to chronic fatigue syndrome, a difficult-to-diagnose disease with no known cure.
Gift establishes cancer cell therapy center
Silicon Valley entrepreneur Jeffrey Rothschild and his wife, Marieke, have provided funding for a new venture at Stanford Medicine to test cancer cell therapies.
Young scientists win Parker Institute awards
The awards are designed to help train the next generation of scientists in cancer immunotherapy by supporting promising young researchers doing innovative work that has the potential for great impact.
Heart disease’s link to shingles explained
People with coronary artery disease face an elevated risk for shingles because aberrant immune cells dial down the body’s immune response to viral pathogens, Stanford research shows.
Psoriatic arthritis drug shows promise
In a randomized clinical trial conducted by researchers at Stanford and more than 100 other medical centers, psoriatic arthritis patients given an injectable biologic drug for 24 weeks showed substantial improvement compared with patients who received placebo injections.
Cancer therapy may work in unexpected way
An antibody to the cell receptor PD-1 may launch a two-pronged assault on cancer by initiating attacks by both T cells and macrophages, a Stanford study has found.